Keypoint Intelligence, the leading provider of data-driven insights for the digital imaging industry, has released its latest report: Wide Format Print Forecast: 2023-2028. This comprehensive study ...
On November 20, 2024, the National Medical Products Administration (NMPA) announced on its official website that the NMPA approved the listing of Zorifertinib Hydrochloride Tablets (trade name: ...